Trademark: 85886219
Status Date
Thursday, June 9, 2022
Registration Number
4760737
Registration Date
Tuesday, June 23, 2015
Filing Date
Tuesday, March 26, 2013
Published for Opposition
Tuesday, November 11, 2014
5 Pharmaceutical products for the treatment of diseases, namely, Alzheimer's disease and other neurodegenerative diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; biopharmaceutical products, namely, reagents, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemical preparations for medical and pharmaceutical purposes, namely, chemicals for diagnosing Alzheimer's disease and other neurodegenerative diseases, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases
1 Chemical products and compositions intended for medical research, namely, reagents, chemical entities and compounds; chemical preparations for scientific purposes, chemical reagents or products for laboratory analyses for monitoring, analyzing and identifying diagnostic targets and therapeutic products, and for conducting research in connection with pharmaceutical sciences; chemical preparations intended for scientific purposes, namely, for leading research in connection with pharmaceutical sciences
42 Research and development of pharmaceutical molecules, compounds, inhibitors, antibodies and biological markers for diagnostic purposes and medicines for treating diseases; research and development of new products and preparations for the treatment of Alzheimer's disease and other neurodegenerative diseases; research and development in the field of pharmaceutical drugs; biological research; biotechnological research; technical research in the field of biotechnology; consultancy in the field of biotechnology
Jun 9, 2022
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jun 9, 2022
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 9, 2022
Case Assigned To Post Registration Paralegal
Dec 21, 2021
Teas Section 8 & 15 Received
Jun 23, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 23, 2015
Registered-Principal Register
May 19, 2015
Notice Of Acceptance Of Statement Of Use E-Mailed
May 16, 2015
Allowed Principal Register - Sou Accepted
May 13, 2015
Statement Of Use Processing Complete
Apr 10, 2015
Use Amendment Filed
May 11, 2015
Case Assigned To Intent To Use Paralegal
Apr 10, 2015
Teas Statement Of Use Received
Mar 10, 2015
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 10, 2015
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 6, 2015
Noa E-Mailed - Sou Required From Applicant
Nov 11, 2014
Official Gazette Publication Confirmation E-Mailed
Nov 11, 2014
Published For Opposition
Oct 22, 2014
Notification Of Notice Of Publication E-Mailed
Oct 3, 2014
Law Office Publication Review Completed
Oct 3, 2014
Approved For Pub - Principal Register
Sep 18, 2014
Teas/Email Correspondence Entered
Sep 18, 2014
Correspondence Received In Law Office
Sep 11, 2014
Teas Request For Reconsideration Received
Sep 11, 2014
Ex Parte Appeal-Instituted
Sep 11, 2014
Jurisdiction Restored To Examining Attorney
Sep 11, 2014
Exparte Appeal Received At Ttab
Mar 11, 2014
Notification Of Final Refusal Emailed
Mar 11, 2014
Final Refusal E-Mailed
Mar 11, 2014
Final Refusal Written
Feb 20, 2014
Teas/Email Correspondence Entered
Feb 20, 2014
Correspondence Received In Law Office
Feb 12, 2014
Assigned To Lie
Feb 5, 2014
Teas Response To Office Action Received
Aug 6, 2013
Notification Of Non-Final Action E-Mailed
Aug 6, 2013
Non-Final Action E-Mailed
Aug 6, 2013
Non-Final Action Written
Jul 8, 2013
Assigned To Examiner
Mar 29, 2013
New Application Office Supplied Data Entered In Tram
Mar 29, 2013
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
